Skip to content

Construction and effect evaluation of the sleep intervention programme for the elderly with mild cognitive impairment based on mindfulness

The effect and brain functional networks mechanism of individualized creative expression cognitive intervention to mild cognitive impairment of the elderly

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000033831
Enrollment
Unknown
Registered
2020-06-14
Start date
2020-06-20
Completion date
Unknown
Last updated
2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild Cognitive Impairment

Interventions

Active control group:Health Education

Sponsors

Fujian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 85 Years

Inclusion criteria

Inclusion criteria: Eligible participants must meet the following criteria: (1) aged 60 to 85 years; (2) diagnosis of MCI; (3) diagnosis of Insomnia; (4) willingness to provide informed consent.

Exclusion criteria

Exclusion criteria: (1) Epilepsy or Obesity; (2) Sleeping medicine addiction; (3) Taking anti-anxiety or anti-depressant medicine; (4) A history of schizophrenia or mental illness; (5) With other serious organ diseases requiring continuous treatment and monitoring; (6) Any form of sleep disorder other than insomnia, such as Obstructive Sleep Apnea, restless legs syndrome, etc. (7) Have serious physical activity disorder, language communication or vision, hearing impairment; (8) Can't use a smartphone, can't Speak Mandarin; (9) Engage in any other form of meditation or mindfulness.

Design outcomes

Primary

MeasureTime frame
Montreal cognitive assessment, MoCA;Pittsburgh Sleep Quality Index,PISQ;

Secondary

MeasureTime frame
Auditory verbal learning test, AVLT;Symbol digital modalities test,SDMT;Boston naming test,BNT;Shape Trails Test,STT;Functional activities questionnaire,FAQ;Insomnia Severity Index, ISI;Geriatric Depression Scale, GDS;Self-Rating Anxiety Scale, SAS;Quality of life-Alzheimer’s disease, QOL-AD;

Countries

China

Contacts

Public ContactHong Li

Fujian Medical University

leehong99@126.com+86 13705070219

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026